Search database
LIST OPTIONS
Filter
40
Filtered Results: 40
Text search: Pfizer- BioNTech Comirnaty Vaccine
Featured
Language
Document type
Guidelines
19
Fact sheets
10
Studies & Reports
5
Online Courses
3
Manuals
2
Strategic & Response Plan
1
Countries / Regions
Brazil
5
Ukraine
4
Russia
4
China
3
Germany
3
Middle East and North Africa
3
Mozambique
2
Argentina
2
Ecuador
2
Kazakhstan
1
Global
1
Western and Central Europe
1
Paraguay
1
Belarus
1
South Africa
1
Eastern Europe
1
Authors & Publishers
World Health Organization WHO
15
Open WHO
3
Ministerio de Salud Argentina
2
Ministerio de Salud Pública de Ecuador
2
OPAS
2
Robert-Koch-Institut RKI, Deutsches Grünes Kreuz
2
World Health Organisation (WHO)
2
Access to Medicine Foundation
1
Bracho C., Martinez C. et al.
1
Deutsches Grünes Kreuz e. V., Marburg, Robert Koch-Institut RKI
1
Dirección de Control de Enfermedades Inmunoprevenibles
1
European Centre for Disease Prevention and Control ECDC
1
Feraud, H.
1
Harding-Zentrum für Risikokompetenz
1
Health Cluster, WHO
1
Infection Prevention and Control UHL, WHO Headquarters
1
Mauder, S.
1
Ministerio da Saude Brasilia
1
Ministerio da Saude, Brasilia
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud OMS
1
Organización Mundial de Saude and OPAS
1
Organização Mundial da Saúde (OMS)
1
Robert-Koch-Instiut RKI
1
Secretaria Extraordinária de Enfrentamento à COVID-19, Brasil
1
Sociedad Paraguaya de Pediatria
1
UK Health Security Agency
1
UNICEF
1
Vygen-Bonnet S, Koch J, Bogdan C, et al.
1
Wesern Cape Government, South Africa
1
Publication Years
Category
COVID-19
18
Guidelines
9
Capacity Building
3
x MEDBOX Issue Brief & Annual Reports x
1
Vaccine-preventable Diseases
1
Policies
1
Women & Child Health
1
Information, Education and Communication (IEC)
1
Studies & Reports
1
Humanitarian Crisis
1
Pharmacy & Technologies
1
Toolboxes
Biontech/Pfizer Comirnaty
16
Country specific documents
9
Immunization Guidelines
6
Logistics & Supply
5
Access & Strategy
4
COVID-19 Vaccination
4
Online Courses & Resources
3
For Health Worker
3
COVID-19 Vaccination Information
3
mRna Vaccines general
3
Booster Doses
3
Communication Material
2
SARS-CoV-2 Variants
2
Vaccination
1
Pediatrics
1
Anamnesis / Screening
1
Infection Control General
1
For General Public & Community
1
For Parents & Children
1
Vaccination & Strategy
1
Videos
1
Vaccine Candidates & Research
1
Dashboards & Resource Platforms
1
Long COVID/ Post-COVID Syndrome
1
Moderna
1
Vector-based Vacines General
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
Research & Pipeline
1
Inactivated COVID-19 Vaccines
1
Essential Medicines
1
Prices and Patents
1
Situation Reports & Updates
1
Global Overview
1
Human Rights & the Right to Health
1
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. fir... more
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at... more
updated version: 04/10/2021 Information about vaccine administration
обновленная версия от 04/10/2021 Информация о введении вакцин
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna Stand 21. Dezember 2021
Временное руководство, Первый выпуск 8 января 2021 г., Обновлено 15 июня 2021 г., Обновлено 19 ноября 2021 г.
Vaccinator's Manual. Pfizer-BioNTech Comirnaty Vaccine
Vaccine handling, storage and Transportation of Pfizer BioNTech COVID-19 COMIRNATY® (Tozinameran)
(Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та Spikevax® виробництва Moderna); Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen) – mit mRNA-Impfstoffen – (Comirnaty® 10 μg bzw. ... more
– (Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та AUFKLÄRUNGSMERKBLATT Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen) – mit mRNA-Impfstoffen – (Comirnaty® 10 μg bzw. 30 μg von BioNTech/Pfizer... more
Available in different languages
Health workers involved in deployment and implementation of COVID-19 vaccination require vaccine-specific knowledge to ensure safe and efficient vaccine delivery. This training provides key information about COVID-19 vaccines through short instructional videos, vaccine explainers, job aids, topic br... more
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab... more
L’ensemble du personnel de santé qui participe au déploiement et à la mise en œuvre de la vaccination contre la COVID-19 doit avoir les connaissances et les compétences requises pour garantir une administration sûre et efficace du vaccin contre la COVID-19. Ce cours de formation fournit des ... more
يحتاج العاملون الصحيون الذين يشاركون في نشر وتنفيذ التطعيم ضد كوفيد-19 إلى معرفة خاصة بكل لقاح لضمان تقديم اللقاحات بشكل آمن وفعال. يوفر هذا التدريب معلومات أساسية ح... more